COVID-19 Pandemic Disrupts Healthcare Services for Cancer Patients

Strategic Insights -

The COVID-19 pandemic has significantly impacted routine monitoring of patients with head and neck cancer (HNC) and oral potentially malignant disorders (OPMDs), leading to delayed diagnoses and worse outcomes. According to a recent study published in Medicina Oral Patologia Oral Y Cirugia Bucal, researchers from the State University of Campinas (UNICAMP) found that patients who experienced progression during the post-pandemic period had a significantly higher risk of worse outcomes.

Key Takeaways:

  • The COVID-19 pandemic caused major disruptions in healthcare services, especially affecting routine monitoring of patients with head and neck cancer (HNC) and oral potentially malignant disorders (OPMDs).
  • A total of 246 patients were evaluated, including 103 patients with HNC and 143 with OPMDs, in the study published in Medicina Oral Patologia Oral Y Cirugia Bucal.
  • Patients who experienced progression during the post-pandemic period had a significantly higher risk of worse outcomes, with a stability after the pandemic linked to better prognosis (OR=4.667; p=0.0051).
  • The study concluded that delays in monitoring may lead to progression or delayed diagnosis, especially in high-risk patients.
  • Researchers found that among HNC, progression was more frequent in the post-pandemic period (26.9%) compared to the later appointment (24%), which was statistically significant (p=0.0011).
  • Survival analysis revealed significantly lower survival rates for the post-pandemic group compared to those followed during subsequent follow-up (HR=0.26; p=0.0013).
  • The study highlights the need for healthcare services to prioritize routine monitoring and follow-up for patients with HNC and OPMDs during the post-pandemic period.

Statistics:

  • A total of 246 patients with HNC and OPMDs were evaluated in the study.
  • Of the 246 patients, 103 had HNC and 143 had OPMDs.
  • Among HNC patients, progression was more frequent in the post-pandemic period (26.9%) compared to the later appointment (24%).
  • The stability after the pandemic was linked to better prognosis (OR=4.667; p=0.0051).
  • Survival analysis revealed significantly lower survival rates for the post-pandemic group (HR=0.26; p=0.0013).

Sources:

  • Consequences of interrupted follow-up in head and neck cancer and oral potentially malignant disorders patients due to the COVID-19 pandemic. Medicina Oral Patologia Oral Y Cirugia Bucal, 2025.
  • Researchers from State University of Campinas (UNICAMP) Provide Details of New Studies and Findings in the Area of COVID-19 (Consequences of interrupted follow-up in head and neck cancer and oral potentially malignant disorders patients due to ...). Cancer Weekly. November 4, 2025; p 155.